Applied Clinical Trials-09-01-2012

Applied Clinical Trials

Bridging US and China to Conquer Cancer

September 01, 2012

News

21

9

During the annual ASCO meeting in June, the US Chinese Anti-Cancer Association (USCACA) held its fourth annual meeting to discuss the emerging role of China in global clinical development of novel anti-cancer drugs.

We Still Love Paper

September 01, 2012

Trends in Central Labs & Biomarkers

21

9

Moving into electronic methods to facilitate laboratory collections for clinical trials.

Flow Cytometry

September 01, 2012

Trends in Central Labs & Biomarkers

21

9

The use of flow cytometry can add value in Phase I studies.

More Transparency, Standards Urged for Research

September 01, 2012

News

21

9

Even though thousands of clinical trials are listed on public websites, and sponsors are posting results from more key studies, consumer advocates continue to press for broader public disclosure of information on research involving human subjects.

A New Paradigm

September 01, 2012

Trends in Central Labs & Biomarkers

21

9

Practical approaches to new challenges and opportunities in inflammation trials.

Regulators Must Modify Approach

September 01, 2012

News

21

9

Regulators must stop approving so many new drugs of very limited therapeutic value, and the European Medicines Agency (EMA) and other regulatory bodies should be fully funded by public money rather than relying on industry-generated user fees, according to an article published by the British Medical Journal.

Multiplexing Advantages

September 01, 2012

Trends in Central Labs & Biomarkers

21

9

Illuminating the advantages of multiplexing for advanced biomarker testing.

Proactive Use

September 01, 2012

Trends in Central Labs & Biomarkers

21

9

Biomarkers help researchers develop new drugs faster and more effectively.

Applied Clinical Trials Digital Edition - September 2012

September 01, 2012

Issue PDF

21

9

eClinical: The Use of ePRO in Diabetes Studies CRO/Sponsor: Managing the Global Supply Chain Also in this issue: Clinical Trial Funding CRO Market Size Biosimilar Development